Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1CNS 1

Conditions

Hematologic Neoplasms 1Brain Neoplasms 1

Interventions

Methylphenidate 2Methods 2sargramostim 1ropidoxuridine 1entrectinib 1entinostat 1cc-486 1carboxyamido-triazole 1bintrafusp alfa protein, human 1Watchful Waiting 1WP 744 1Vincristine 1Thalidomide 1Temozolomide 1Ritonavir 1Radiotherapy 1Quality of Life 1Psychology, Positive 1Psychiatric Rehabilitation 1Pemetrexed 1Patient Reported Outcome Measures 1Paclitaxel 1Observation 1O(6)-benzylguanine 1N-(2,3-dihydroxypropyl)-1-((2-fluoro-4-iodophenyl)amino)isonicotinamide 1Molecular Diagnostic Techniques 1Megestrol Acetate 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × ropidoxuridine × Other hematologic neoplasm × Clear all
NCT02993146 2026-04-30

Ropidoxuridine and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases

National Cancer Institute (NCI)

Phase 1 Active not recruiting
11 enrolled 12 charts
CNSOther hematologic neoplasm

Brain Neoplasms, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡